Hospital outcomes and complications of anterior and posterior cervical fusion with bone morphogenetic protein

Spine

Volumn 38, Issue 15, 2013, Pages 1304-1309

  Fineberg, Steven J ^a   Ahmadinia, Kasra ^a   Oglesby, Matthew ^a   Patel, Alpesh A ^b   Singh, Kern ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

anterior cervical fusion; BMP; bone morphogenetic protein; cervical myelopathy; cervical radiculopathy; Cervical spine surgery; complications; national trends; Nationwide Inpatient Sample; NIS; posterior cervical fusion; risk factors

Indexed keywords

BONE MORPHOGENETIC PROTEIN;

ADULT; ANTERIOR SPINE FUSION; ARTICLE; BLEEDING; CERVICAL MYELOPATHY; CERVICAL SPINE; CERVICAL SPINE ANTERIOR FUSION; COMORBIDITY; COST; DEMOGRAPHY; DYSPHAGIA; FEMALE; HEART DISEASE; HEMATOMA; HOSPITAL; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION; LENGTH OF STAY; LIQUORRHEA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGICAL COMPLICATION; OUTCOME ASSESSMENT; POSTERIOR CERVICAL FUSION; POSTERIOR SPINE FUSION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE SHOCK; PRIORITY JOURNAL; RADICULOPATHY; RETROSPECTIVE STUDY; SHOCK;

BONE MORPHOGENETIC PROTEINS; CERVICAL VERTEBRAE; COMORBIDITY; DEGLUTITION DISORDERS; FEMALE; HOSPITAL COSTS; HUMANS; INCIDENCE; INPATIENTS; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SPINAL FUSION; SURVIVAL RATE; UNITED STATES;

EID: 84879951054     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e31828f494c     Document Type: Article

References (23)

1. Ahlmann E, Patzakis M, Roidis N, et al. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site mor-bidity and functional outcomes. J Bone Joint Surg Am 2002; 84-A: 716-20.
2. Kim DH, Rhim R, Li L, et al. Prospective study of iliac crest bone graft harvest site pain and morbidity. Spine J 2009; 9: 886-92.
3. Kurz LT, Garfin SR, RE B. Harvesting autogenous iliac crest bone grafts: a review of complications and techniques. Spine 1989; 14: 1324-31.
4. Urist MR. Bone: formation by autoinduction. 1965. Clin Orthop Relat Res 2002: 4-10.
5. Matthews SJ. Biological activity of bone morphogenetic proteins (BMP's). Injury 2005; 36 (suppl 3): S34-7.
6. Fehlings MG, Smith JS, Kopjar B, et al. Perioperative and delayed complications associated with the surgical treatment of cervical spondylotic myelopathy based on 302 patients from the AOSpine North America Cervical Spondylotic Myelopathy Study. J Neurosurg Spine 2012; 16: 425-32.
7. Brambilla S, Ruosi C, La Maida GA, et al. Prevention of venous thromboembolism in spinal surgery. Eur Spine J 2004; 13: 1-8.
8. Lad SP, Nathan JK, Boakye M. Trends in the use of bone morpho-genetic protein as a substitute to autologous iliac crest bone grafting for spinal fusion procedures in the United States. Spine (Phila Pa 1976) 2011; 36: E274-81.
9. Smucker JD, Rhee JM, Singh K, et al. Increased swelling complica-tions associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine (Phila Pa 1976) 2006; 31: 2813-9.
10. Shields LB, Raque GH, Glassman SD, et al. Adverse effects associ-ated with high-dose recombinant human bone morphogenetic pro-tein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976) 2006; 31: 542-7.
11. Buttermann GR. Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion. Spine J 2008; 8: 426-35.
12. Rokito SE, Schwartz MC, Neuwirth MG. Deep vein thrombosis after major reconstructive spinal surgery. Spine 1996; 21: 853-8; dis-cussion 9.
13. Crawford CH, 3rd, Carreon LY, McGinnis MD, et al. Periopera-tive complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis. Spine (Phila Pa 1976) 2009; 34: 1390-4.
14. Hiremath GK, Steinmetz MP, Krishnaney AA. Is it safe to use recombinant human bone morphogenetic protein in posterior cer-vical fusion? Spine 2009; 34: 885-9.
15. Hodges SD, Eck JC, Newton D. Retrospective study of pos-terior cervical fusions with rhBMP-2. Orthopedics 2012; 35: e895-8.
16. Cahill KS, Chi JH, Day A, et al. Prevalence, complications, and hos-pital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA 2009; 302: 58-66.
17. Healthcare Cost and Utilization Project (HCUP): Overview of the Nationwide Inpatient Sample (NIS) [Agency for Healthcare Research and Quality], 2002-2009. Available at: www.hcup-us. ahrq.gov/nisoverview.jsp. Accessed March 22, 2013.
18. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
19. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a com-bined comorbidity index. J Clin Epidemiol 1994; 47: 1245-51.
20. Vaidya R, Carp J, Sethi A, et al. Complications of anterior cervical discectomy and fusion using recombinant human bone morphoge-netic protein-2. Eur Spine J 2007; 16: 1257-65.
21. Ackerman SJ, Mafilios MS, Polly DW Jr. Economic evaluation of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion: an evidence-based mod-eling approach. Spine (Phila Pa 1976) 2002; 27: S94-9.
22. Glassman SD, Carreon LY, Campbell MJ, et al. The perioperative cost of infuse bone graft in posterolateral lumbar spine fusion. Spine J 2008; 8: 443-8.
23. Romano PS, Chan BK, Schembri ME, et al. Can administrative data be used to compare postoperative complication rates across hospi-tals? Med Care 2002; 40: 856-67.